Estimating NT-proBNP and left ventricular ejection fraction in T2DM patients is an important step in evaluating cardiac function, which helps in early identification, timely intervention, and management of cardiovascular complications effectively. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.